Detalhe da pesquisa
1.
Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
J Clin Microbiol
; 61(6): e0183222, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249422
2.
Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial.
BMC Infect Dis
; 21(1): 183, 2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596848
3.
Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review.
Front Immunol
; 14: 1249878, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781385
4.
Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study.
Int J Infect Dis
; 135: 101-108, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567554
5.
Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis.
Int J Infect Dis
; 111: 138-147, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454119
6.
Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China.
Clin Microbiol Infect
; 27(7): 1000-1006, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421578